Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ: REGN )

582.52 USD -3.22 (-0.55%)
Official Closing Price Updated: 5:33 PM EDT, Oct 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 525,680
Open 584.98
Bid (Size) 579.89 (4)
Ask (Size) 582.50 (2)
Prev. Close 585.74
Today's Range 579.04 - 590.97
52wk Range 303.22 - 664.64
Shares Outstanding 105,949,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Regeneron Announces Investor Conference Presentations
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: 
From PR Newswire
Dupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms presented for the first time at scientific meetings
From GlobeNewswire News Releases

Performance

YTD
+56.03%
+56.03%
1 Month
+1.85%
+1.85%
3 Month
-8.61%
-8.61%
6 Month
+6.39%
+6.39%
1 Year
+88.79%
+88.79%

More News

Read More
Dupixent® (dupilumab) Late-breaking Pivotal Data Showing Significant Improvement in Eosinophilic Esophagitis Signs and Symptoms Presented for the First Time at Scientific Meetings
From PR Newswire
Are These The Best Biotech Stocks To Buy Before November 2020?
From Stockmarket.com
CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis
From GlobeNewswire News Releases
Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)
From Business Wire News Releases
CHMP Recommends Approval of Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Severe Atopic Dermatitis
From PR Newswire
NIAID Study Finds Eli Lilly's Antibody Drug Unhelpful For Hospitalized COVID-19 Patients
Tags Coronavirus Health Care the National Institute of Allergy and Infectious Diseases
From Benzinga
2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)
From Business Wire News Releases
Regeneron Pharmaceuticals Now #109 Largest Company, Surpassing Micron Technology
Tags Stocks
From Market News Video
Pfizer, Moderna Vaccines, Gilead Treatment In Focus As Health Firms Report Q3 Earnings
Tags Earnings Market News MRNA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.